Given the major roles of PI3K/mTOR and Hsp90 in regulating tumor cell motility, we evaluated in this study whether their inhibitors, PI-103 and NVP-AUY922 (hereafter denoted as AUY922) have potential as anti-migratory agents in GBM. The gene discussed is MTOR; the disease is glioblastoma.